Latest News

Page 18 of 31« First...10...1617181920...30...Last »

August 12, 2014

Low Vision Conferences Becoming High-Tech Accessible

Posted in: Latest News

Organizations for the blind and visually impaired will soon be able to provide indoor navigation technology at their national conferences. The service, called “Audio Guide”, is being offered free gratis to charitable organizations by Macular Degeneration Support, with financial backing by Macular Degeneration Foundation. Beginning in 2015, conference attendees will be able to more easily
read more »

July 30, 2014

Eylea Approved For Diabetic Macular Edema

Posted in: Latest News

Regeneron Pharmaceuticals has announced that the FDA has approved Eylea (aflibercept) injection for treatment of diabetic macular edema (DME) in the U.S. Eylea now joins Genentech’s Lucentis (ramabizumab) as a treatment for DME in addition to neovascular (wet) age-related macular degeneration and macular edema after central retinal vein occlusion. Aflibercept has also been approved for
read more »

July 9, 2014

New Approach to Low Vision Rehab Cuts Risk of Depression in Half

Posted in: Latest News, Low Vision Rehabilitation

Depression is a common risk for people who have lost their vision, but a new study shows that a new approach called “behavior activation” can cut the risk in half. Researchers from Wilmer Eye Institute, Sidney Kimmel Medical College, and Wills Eye Hospital have announced results from their Low Vision Depression Prevention Trial (VITAL), designed
read more »

July 7, 2014

Catching The Big One

Posted in: Latest News

by Dan Roberts Caregivers of older adults have understandable concerns about potential suicide when their loved ones begin talking about death. They may, however, be worrying unnecessarily. During those moments, three questions need to be considered: 1. Is the person depressed? 2. Is the person suicidal? 3. Is the person simply sharing personal thoughts? Risk
read more »

July 4, 2014

Myopia: Genetic or Environmental?

Posted in: Eye Conditions, Latest News

by Dan Roberts Ophthalmic nearsightedness (myopia) results from an abnormal elongation of the eyeball during the growing years. This extra “axial length” causes objects at a distance to appear out of focus, which can usually be corrected with prescription glasses. The physical aspects of extreme nearsightedness (hypermyopia), however, can lead to a type of uncorrectable
read more »

June 25, 2014

Blindness Can Be Prevented Now

Posted in: Daily Living, Latest News

Editorial by Dan Roberts, Editor-in-Chief Prevent Blindness Since 1908, Prevent Blindness has been living up to its name by educating the public about early prevention and detection. It has done this by way of vision screenings, educational programs, research support, and advocacy. But the organization hasn’t stopped there. It realizes that preventing blindness means more
read more »

June 24, 2014

New research on UV rays and cataract

Posted in: Latest News, Research and Developments

Courtesy: National Eye Institute, National Institutes of Health (NEI/NIH) A new study offers an explanation for how years of chronic sunlight exposure can increase the risk of cataract, a clouding of the eye lens that typically occurs with aging. The study firms up a link between the sun’s damaging rays and a process called oxidative
read more »

June 24, 2014

Squalamine Eye Drops Under Study for Wet AMD

Posted in: Latest News, Research and Developments

(Updated 4/17/16) On June 24, 2014, Ohr Pharmaceutical, Inc. announced positive top-line interim results for its Phase 2 clinical trial of Squalamine eye drops in patients with wet age-related macular degeneration (wet AMD). The data demonstrated a positive benefit in multiple visual function including a gain in visual acuity of +10.4 letters with Squalamine eye
read more »

June 20, 2014

StemCells, Inc. Closes Enrollment in Dry AMD Trial

Posted in: Latest News

Phase II Clinical Trial to Begin This Year StemCells, Inc. yesterday announced that, based on positive interim results, it has closed enrollment in its Phase I/II clinical trial for dry age-related macular degeneration (AMD) in order to focus its efforts on a follow-on Phase II randomized, controlled proof-of-concept study. Exceeding the company’s expectations, interim results showed
read more »

June 17, 2014

Omega-3 Inhibits Retinal Blood Vessel Growth

Posted in: Latest News, Research and Developments

Researchers from Massachusetts Eye and Ear/Schepens Eye Research Institute, Harvard Medical School and other institutions have demonstrated for the first time that the omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), DHA and EPA, can inhibit choroidal neovascularization (CNV). Their findings will be published in PNAS Online Early Edition the week of June 16-20, 2014. “These are
read more »

Page 18 of 31« First...10...1617181920...30...Last »

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann